Back to search results

A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

Abroad (travel likely)RecruitingPHASE3

Conditions

Paroxysmal Nocturnal Hemoglobinuria

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Toronto General Hospital, Toronto, Ontario, Canada

  • Hospital Pablo Tobon Uribe, Medellín, Antioquia, Colombia

  • Semmelweis University/Semmelweis Egyetem, Budapest, Hungary

  • Amrita Institute of Medical Sciences (AIMS) and Research Centre Aims, Kochi, Kerala, India

  • K J Somaiya Super Specialty Hospital & Research Centre, Mumbai, Maharashtra, India

  • Rajiv Gandhi Cancer Institute & Research Center (RGCIRC) - Rohini Campus, New Delhi, National Capital Territory of Delhi, India

  • Postgraduate Institute of Medical Education & Research, Chandigarh, India

  • Bhagwan Mahaveer Cancer Hospital and Research Centre (BMCHRC), Jaipur, India

  • Aou Careggi, Florence, Firenze, Italy

  • SC Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy

  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Aichi-ken, Japan

  • University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan

  • Jordan University Hospital (JUH), Amman, Jordan

  • Hospital Tg Ampuan Afzan, Kuantan, Pahang, Malaysia

  • Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia

  • Hospital Ampang, Ampang, Selangor, Malaysia

  • Clinica San Felipe, Lima, Peru

  • St Lukes Medical Center, Quezon City, National Capital Region, Philippines

  • In-Vivo Sp. z o.o., Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

  • University Clinical Center Medical University of Gdansk, Gdansk, Pomeranian Voivodeship, Poland

  • Szpital Uniwersytecki Nr2 Bydgoszcz, Bydgoszcz, Poland

  • Prof Dr Ion Chiricuta Cancer Institute, Cluj-Napoca, Cluj, Romania

  • National University Hospital, Singapore, Singapore

  • St. Vincent Hospital, Suwon, Gyeonggi-do, South Korea

  • Ajou University Medical Center, Suwon, Gyeonggi-do, South Korea

  • Gachon University Gil Medical Center, Incheon, Namdong-Gu, South Korea

  • Pusan National University Hospital, Busan, South Korea

  • Severance Hospital Yonsei University Health System, Seoul, South Korea

  • Samsung Medical Center, Seoul, South Korea

  • The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, South Korea

  • Ewha Womans University Mokdong Hospital, Seoul, South Korea

  • Hospital Universitario Basurto, Bilbao, Vizcaya, Spain

  • Hospital Clinic de Barcelona, Barcelona, Spain

  • China Medical University Hospital, Taichung, Central Taiwan, Taiwan

  • Chang Gung Memorial Hospital - Linkou Branch, Taoyuan, Hunan Province, Taiwan

  • Hualien Tzu Chi Hospital, Hualien City, Taiwan

  • National Taiwan University Hospital, Taipei, Taiwan

  • Tri-Service General Hospital, Taipei, Taiwan

  • Prince Of Songkla Hospital, Prince Of Songkhla University, Hat Yai, Changwat Songkhla, Thailand

  • King Chulalongkorn Memorial Hospital, Bangkok, Thailand

  • Chiang Mai University, Chiang Mai, Thailand

  • Faculty of Medicine Khon Kaen University, Khon Kaen, Thailand

  • Ege University Faculty of Medicine, Bornova, İzmir, Turkey (Türkiye)

  • Istanbul University, Istanbul, Turkey (Türkiye)

  • Leeds Teaching Hospitals NHS Trust - St. James Institute of Oncology, Leeds, United Kingdom

Study leads

  • Clinical Trial Management

    Study Director

    Regeneron Pharmaceuticals

View source on ClinicalTrials.gov(opens in a new tab)